Early research (Phase 1)Study completedNCT01331135What this trial is testingAflac ST0901 CHOANOME - Sirolimus in Solid TumorsWho this might be right forEwing's SarcomaOsteosarcomaAstrocytoma+13 more Emory University 18
Early research (Phase 1)WithdrawnNCT01236586What this trial is testingRO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forLymphomaBrain NeoplasmsSarcoma+2 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03233204What this trial is testingOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Looking for participantsNCT05135975What this trial is testingCabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsWho this might be right forNeuroblastomaSarcoma Nationwide Children's Hospital 86
Testing effectiveness (Phase 2)Study completedNCT03761914What this trial is testingGalinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersWho this might be right forAcute Myelogenous LeukemiaOvarian CancerColorectal Cancer+2 more Sellas Life Sciences Group 26
Not applicableStudy completedNCT05755633What this trial is testingRole of Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and Mortality After Allogeneic Stem Cell TransplantationWho this might be right forAssessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686334What this trial is testingEfficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in RemissionWho this might be right forAcute Myeloid Leukemia Zwi Berneman 130
Early research (Phase 1)Study completedNCT01598454What this trial is testingUse of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated GangliosidesWho this might be right forNeuroblastomaEwing's SarcomaWilm's Tumor+2 more Laboratorio Elea Phoenix S.A. 15
Not applicableStudy completedNCT06190574What this trial is testingDiagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid BlastomaWho this might be right for18F-FDGNeuroblastomaHepatoblastoma+1 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Early research (Phase 1)Looking for participantsNCT04715191What this trial is testingInterleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsWho this might be right forLiver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more Baylor College of Medicine 24
Not applicableStudy completedNCT00152126What this trial is testingChemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasWho this might be right forNeuroblastomaCentral Nervous System TumorsLymphomas+1 more St. Jude Children's Research Hospital 26
Early research (Phase 1)Active Not RecruitingNCT04377932What this trial is testingInterleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsWho this might be right forLiver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more Baylor College of Medicine 14
Early research (Phase 1)Study completedNCT00398138What this trial is testingVaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaWho this might be right forLeukemiaLung CancerMalignant Mesothelioma+2 more Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00052520What this trial is testingBiological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell TransplantationWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+20 more Fred Hutchinson Cancer Center 37
Large-scale testing (Phase 3)UnknownNCT01809392What this trial is testingDecitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeWho this might be right forAcute Myelocytic LeukemiaMyelodysplastic Syndromes The First Affiliated Hospital of Soochow University 15
Testing effectiveness (Phase 2)Study completedNCT00141765What this trial is testingStudy of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis CancersWho this might be right forWilms TumorFibrosarcomaCarcinoma, Round Cell+2 more University of Michigan Rogel Cancer Center 25
Early research (Phase 1)Looking for participantsNCT04308330What this trial is testingVorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS MalignanciesWho this might be right forEwing SarcomaRhabdomyosarcomaWilms Tumor+3 more New York Medical College 30
Early research (Phase 1)Study completedNCT00725283What this trial is testingEvaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)Who this might be right forLeukaemia, Myelocytic, Acute GlaxoSmithKline 34
Early research (Phase 1)Looking for participantsNCT07645469What this trial is testingFH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Fred Hutchinson Cancer Center 9
Early research (Phase 1)Study completedNCT01453283What this trial is testingTabectedin to Treat Children and Adolescents With CancerWho this might be right forSolid Tumors National Cancer Institute (NCI) 12